go back

Dolasetron, Oral

Rhode Island rates for HCPCS Q0180

Dolasetron mesylate, 100 mg, oral, FDA-approved prescription antiemetic, for use as a complete therapeutic substitute for an IV antiemetic at the time of chemotherapy treatment, not to exceed a 24-hour dosage regimen

Rates data updated July 2026.

Facilitymedian $65 · 10th–90th $62$2340%50%10th90th$65Professionalmedian $62 · 10th–90th $59$620%50%10th$62$50.0$100.0$200.0

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$117.49
Median
$234.42
Typical High
$234.42
Aetna
Setting
Professional
Modifier
Global
Typical Low
$58.88
Median
$61.66
Typical High
$61.66
BCBS
Setting
Facility
Modifier
Global
Typical Low
$64.57
Median
$64.57
Typical High
$67.61
BCBS
Setting
Professional
Modifier
Global
Typical Low
$64.57
Median
$64.57
Typical High
$64.57
Cigna
Setting
Facility
Modifier
Global
Typical Low
$61.66
Median
$61.66
Typical High
$117.49
Cigna
Setting
Professional
Modifier
Global
Typical Low
$61.66
Median
$61.66
Typical High
$61.66
United
Setting
Professional
Modifier
Global
Typical Low
$60.26
Median
$60.26
Typical High
$97.72